Overall, intratumoral administration of exoSTING to tumor-bearing mice resulted in a robust and long-lasting anti-tumor response, which was highly dependent on TAM and CD8+ T cell effector mechanisms [60,96,97]. This evidence concerns the gene CD8A and neoplasm.